FDA Approved: BACLOFEN — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for baclofen submitted by Chartwell RX, LLC under ANDA 077241.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Spinal Cord Injury

Drugs mentioned

• BACLOFEN (Baclofen)

Snippet

SUPPL AP for BACLOFEN (BACLOFEN)